H Okada,
P Kalinski,
R Ueda,
A Hoji,
G Kohanbash,
TE Donegan,
AH Mintz,
JA Engh,
DL Bartlett,
CK Brown,
H Zeh,
MP Holtzman,
TA Reinhart,
TL Whiteside,
LH Butterfield,
RL Hamilton,
DM Potter,
IF Pollack,
AM Salazar,
FS Lieberman.
(2010)
" Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With {alpha}-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma.
"
J Clin Oncol
29.
330-6
PMID:
21149657
DOI:
10.1200/JCO.2010.30.7744
|
Abstract and Keywords
LM Wood,
ZK Pan,
P Guirnalda,
P Tsai,
M Seavey,
Y Paterson.
(2011)
" Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.
"
Cancer Immunol Immunother
60.
931-42
PMID:
21431419
DOI:
10.1007/s00262-011-1002-x
|
Abstract and Keywords
H Xiao,
Y Peng,
Y Hong,
Y Liu,
ZS Guo,
DL Bartlett,
N Fu,
Y He.
(2011)
" Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.
"
J Immunol
187.
1788-96
PMID:
21746967
DOI:
10.4049/jimmunol.1101138
|
Abstract and Keywords
OE Rahma,
E Ashtar,
M Czystowska,
ME Szajnik,
E Wieckowski,
S Bernstein,
VE Herrin,
MA Shams,
SM Steinberg,
M Merino,
W Gooding,
C Visus,
AB Deleo,
JK Wolf,
JG Bell,
JA Berzofsky,
TL Whiteside,
SN Khleif.
(2011)
" A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
"
Cancer Immunol Immunother
61.
373-84
PMID:
21927947
DOI:
10.1007/s00262-011-1100-9
|
Abstract and Keywords
S Fresnay,
X Zhang,
SE Strome,
DA Sewell.
(2011)
" Bone marrow vaccination: a novel approach to enhance antigen specific antitumor immunity.
"
Vaccine
29.
8599-605
PMID:
21951877
DOI:
10.1016/j.vaccine.2011.09.022
|
Abstract and Keywords
YA Aldhamen,
SS Seregin,
NJ Schuldt,
DP Rastall,
CJ Liu,
S Godbehere,
A Amalfitano.
(2012)
" Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity.
"
J Immunol
189.
1349-59
PMID:
22745373
DOI:
10.4049/jimmunol.1200736
|
Abstract and Keywords